Vitalhub Corp. (TSE:VHI - Get Free Report)'s stock price hit a new 52-week high during mid-day trading on Thursday . The company traded as high as C$10.21 and last traded at C$10.20, with a volume of 27975 shares changing hands. The stock had previously closed at C$9.51.
Analyst Ratings Changes
Separately, Cormark lifted their price target on shares of Vitalhub from C$9.50 to C$10.50 and gave the stock a "buy" rating in a research note on Wednesday, October 2nd.
View Our Latest Report on Vitalhub
Vitalhub Trading Up 7.3 %
The business's 50 day simple moving average is C$8.80 and its 200 day simple moving average is C$7.73. The company has a market cap of C$518.67 million, a P/E ratio of 91.55, a PEG ratio of 1.18 and a beta of 1.26.
Vitalhub (TSE:VHI - Get Free Report) last issued its earnings results on Thursday, August 8th. The company reported C($0.01) earnings per share (EPS) for the quarter, missing the consensus estimate of C$0.06 by C($0.07). Vitalhub had a net margin of 8.14% and a return on equity of 4.73%. The business had revenue of C$16.24 million for the quarter, compared to the consensus estimate of C$15.39 million. Sell-side analysts anticipate that Vitalhub Corp. will post 0.2296467 EPS for the current year.
About Vitalhub
(
Get Free Report)
Vitalhub Corp., together with its subsidiaries, provides technology solutions for health and human service providers in Canada, the United States, the United Kingdom, Australia, Western Asia, and internationally. Its solutions include electronic healthcare record, case management, care coordination and optimization, and patient flow, engagement, and operational visibility solutions.
See Also
Before you consider Vitalhub, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Vitalhub wasn't on the list.
While Vitalhub currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
